Hypophosphatemia Risk Associated With Intravenous Iron Therapies For Iron Deficiency Anemia

Home / Intelligence / Scientific Publications / Hypophosphatemia Risk Associated With Intravenous Iron Therapies For Iron Deficiency Anemia

The purpose of this study was to systematically assess rates of treatment-emergent hypophosphatemia among IDI formulations used in IDA.

Authors

Lim-Watson M, Libre M, Karkare S, Alkhateeb Z, Hadker N, Bajic-Lucas A, Dahl N, Strauss W, Glaspy J

Journal

ISPOR Meeting, May 2019

View publication

Related Intelligence

Scientific Publications

ISPOR US 2024 Research Posters

Healthcare Resource Utilization of Patients with Short Bowel Syndrome Dependent on Parenteral Support: A Retrospective Claims Analysis AUTHOR(S): Ali A1, Micic D2, Gallivan M1, Kulkarni A3, Henderson J4, Mitchell G4 1Trinity Life Sciences, Waltham, MA, USA, 2University of Chicago Medical Center, Gastroenterology, Hepatology, and Nutrition, Chicago, IL, USA, 3Trinity Life Sciences, Malden, MA, USA, 4VectivBio AG, Basel, Basel, Switzerland […]

Scientific Publications

ISPOR EU 2023 Research Posters

Implications of the Implementation of the Joint Committee Assessment on Launch Planning for Medical Technologies in Europe Acosta Luis S1, O’Hara M2, Yeh M2 1Trinity Partners, LLC, London, UK, 2Trinity Life Sciences, Waltham, MA, USA The EU-wide Joint Clinical Assessment (JCA) is set to be operational from January 2025. The Trinity team reviewed the available literature […]

Scientific Publications

ISPOR US 2023 Research Posters

Health Equity Frameworks – Healthcare System Actions and Priorities Gulaid A1, Goldman E2, Skaar J1, Dehipawala S3 1Trinity Life Sciences, New York, NY, USA, 2Trinity Life Sciences, Waltham, MA, USA, 3Trinity Life Sciences, Bellerose, NY, USA Health equity has been defined as attainment of the highest level of health for all people, regardless of race, ethnicity, disability, […]